Tyra Biosciences, Inc. Earnings Per Share (Basic)
Tyra Biosciences, Inc. (TYRA) reported Earnings Per Share (Basic) of -$0.69 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-04
- Tyra Biosciences, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.69.
- Tyra Biosciences, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.64.
- Tyra Biosciences, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.57.
- Tyra Biosciences, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.50.
- Tyra Biosciences, Inc. earnings per share, basic for fiscal 2025 was -$2.01.
- Tyra Biosciences, Inc. earnings per share, basic for fiscal 2024 was -$1.51.
- Tyra Biosciences, Inc. earnings per share, basic for fiscal 2023 was -$1.62.
- Tyra Biosciences, Inc. earnings per share, basic for fiscal 2022 was -$1.32.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.69 10-Q · filed 2026-08-04 | -$1.33 10-Q · filed 2026-08-04 | -$1.90 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$2.40 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2026-03-31 | -$0.64 10-Q · filed 2026-05-13 | -$1.20 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$1.70 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$2.18 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2025-12-31 | -$0.57 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$1.07 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$1.54 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$2.01 10-K · filed 2026-03-02 |
| 2025-09-30 | -$0.50 10-Q · filed 2025-11-05 | -$0.97 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$1.45 10-Q · filed 2025-11-05 | -$1.88 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2025-06-30 | -$0.47 10-Q · filed 2026-08-04 | -$0.95 10-Q · filed 2026-08-04 | -$1.38 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$1.79 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2025-03-31 | -$0.47 10-Q · filed 2026-05-13 | -$0.91 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$1.32 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$1.63 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2024-12-31 | -$0.43 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$0.84 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$1.16 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$1.51 10-K · filed 2026-03-02 |
| 2024-09-30 | -$0.41 10-Q · filed 2025-11-05 | -$0.73 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$1.08 10-Q · filed 2025-11-05 | -$1.57 derived: net income ÷ weighted average shares · filed 2025-11-05 |
| 2024-06-30 | -$0.32 10-Q · filed 2025-08-14 | -$0.67 10-Q · filed 2025-08-14 | -$1.16 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$1.64 derived: net income ÷ weighted average shares · filed 2025-11-05 |
| 2024-03-31 | -$0.35 10-Q · filed 2025-05-08 | -$0.86 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$1.35 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$1.67 derived: net income ÷ weighted average shares · filed 2025-11-05 |
| 2023-12-31 | -$0.53 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$1.02 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$1.34 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$1.62 10-K · filed 2025-03-27 |
| 2023-09-30 | -$0.49 10-Q · filed 2024-11-07 | -$0.81 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$1.09 10-Q · filed 2024-11-07 | -$1.39 derived: net income ÷ weighted average shares · filed 2024-11-07 |
| 2023-06-30 | -$0.31 10-Q · filed 2024-08-07 | -$0.59 10-Q · filed 2024-08-07 | -$0.90 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$1.20 derived: net income ÷ weighted average shares · filed 2024-11-07 |
| 2023-03-31 | -$0.28 10-Q · filed 2024-05-09 | -$0.59 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$0.88 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$1.24 derived: net income ÷ weighted average shares · filed 2024-11-07 |
| 2022-12-31 | -$0.31 derived: net income ÷ weighted average shares · filed 2024-03-19 | -$0.60 derived: net income ÷ weighted average shares · filed 2024-03-19 | -$0.96 derived: net income ÷ weighted average shares · filed 2024-03-19 | -$1.32 10-K · filed 2024-03-19 |
| 2022-09-30 | -$0.30 10-Q · filed 2023-11-07 | -$0.66 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$1.02 10-Q · filed 2023-11-07 | -$1.25 derived: net income ÷ weighted average shares · filed 2023-11-07 |
| 2022-06-30 | -$0.36 10-Q · filed 2023-08-10 | -$0.72 10-Q · filed 2023-08-10 | -$0.96 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$1.39 derived: net income ÷ weighted average shares · filed 2023-11-07 |
| 2022-03-31 | -$0.36 10-Q · filed 2023-05-04 | -$0.60 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$1.02 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$1.56 derived: net income ÷ weighted average shares · filed 2023-11-07 |
| 2021-12-31 | -$0.24 derived: net income ÷ weighted average shares · filed 2023-03-22 | -$0.65 derived: net income ÷ weighted average shares · filed 2023-03-22 | -$1.25 derived: net income ÷ weighted average shares · filed 2023-03-22 | -$1.91 10-K · filed 2023-03-22 |
| 2021-09-30 | -$0.72 10-Q · filed 2022-11-03 | -$2.13 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$3.63 10-Q · filed 2022-11-03 | |
| 2021-06-30 | -$2.43 10-Q · filed 2022-08-04 | -$4.54 10-Q · filed 2022-08-04 | ||
| 2020-09-30 | -$0.77 derived: net income ÷ weighted average shares · filed 2021-11-03 | -$1.93 derived: net income ÷ weighted average shares · filed 2021-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |